<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36229415</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>30</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1976-670X</ISSN><JournalIssue CitedMedium="Internet"><Volume>55</Volume><Issue>12</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>BMB reports</Title><ISOAbbreviation>BMB Rep</ISOAbbreviation></Journal><ArticleTitle>Acid sphingomyelinase inhibition improves motor behavioral deficits and neuronal loss in an amyotrophic lateral sclerosis mouse model.</ArticleTitle><Pagination><StartPage>621</StartPage><EndPage>626</EndPage><MedlinePgn>621-626</MedlinePgn></Pagination><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease characterized by the degeneration of motor neurons in the spinal cord. Main symptoms are manifested as weakness, muscle loss, and muscle atrophy. Some studies have reported that alterations in sphingolipid metabolism may be intimately related to neurodegenerative diseases, including ALS. Acid sphingomyelinase (ASM), a sphingolipid-metabolizing enzyme, is considered an important mediator of neurodegenerative diseases. Herein, we show that ASM activity increases in samples from patients with ALS and in a mouse model. Moreover, genetic inhibition of ASM improves motor function impairment and spinal neuronal loss in an ALS mouse model. Therefore, these results suggest the role of ASM as a potentially effective target and ASM inhibition may be a possible therapeutic approach for ALS. [BMB Reports 2022; 55(12): 621-626].</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Byung Jo</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>KNU Alzheimer's Disease Research Institute, Kyungpook National University, Daegu 41566; Department of Laboratory Animal Medicine, College of Veterinary Medicine, Kyungpook National University, Daegu 41566, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Kang Ho</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>KNU Alzheimer's Disease Research Institute, Kyungpook National University, Daegu 41566; Department of Physiology, School of Medicine, Kyungpook National University, Daegu 41944, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Min Hee</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>KNU Alzheimer's Disease Research Institute, Kyungpook National University, Daegu 41566; Department of Physiology, School of Medicine, Kyungpook National University, Daegu 41944, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Eric Jinsheng</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Pathology, University of California San Francisco, San Francisco, CA 94143, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Seung Hyun</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hanyang University College of Medicine, Seoul 04763, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bae</LastName><ForeName>Jae-Sung</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>KNU Alzheimer's Disease Research Institute, Kyungpook National University, Daegu 41566; Department of Physiology, School of Medicine, Kyungpook National University, Daegu 41944, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Hee Kyung</ForeName><Initials>HK</Initials><AffiliationInfo><Affiliation>KNU Alzheimer's Disease Research Institute, Kyungpook National University, Daegu 41566; Department of Laboratory Animal Medicine, College of Veterinary Medicine, Kyungpook National University, Daegu 41566, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016433">News</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>BMB Rep</MedlineTA><NlmUniqueID>101465334</NlmUniqueID><ISSNLinking>1976-6696</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.1.4.12</RegistryNumber><NameOfSubstance UI="D013108">Sphingomyelin Phosphodiesterase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013108" MajorTopicYN="N">Sphingomyelin Phosphodiesterase</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>
<b>CONFLICTS OF INTEREST</b>
. The authors have no conflicting interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>13</Day><Hour>22</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36229415</ArticleId><ArticleId IdType="pmc">PMC9813424</ArticleId><ArticleId IdType="pii">5717</ArticleId><ArticleId IdType="doi">10.5483/BMBRep.2022.55.12.142</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. New Engl J Med. 2001;344:1688&#x2013;1700. doi: 10.1056/NEJM200105313442207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200105313442207</ArticleId><ArticleId IdType="pubmed">11386269</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Logroscino G, Hardiman O, et al. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009;10:310&#x2013;323. doi: 10.3109/17482960802566824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960802566824</ArticleId><ArticleId IdType="pmc">PMC3515205</ArticleId><ArticleId IdType="pubmed">19922118</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou ZY, Zhou ZR, Che CH, Liu CY, He RL, Huang HP. Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatr. 2017;88:540&#x2013;549. doi: 10.1136/jnnp-2016-315018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-315018</ArticleId><ArticleId IdType="pubmed">28057713</ArticleId></ArticleIdList></Reference><Reference><Citation>Boylan K. Familial ALS. Neurol Clin. 2015;33:807&#x2013;830. doi: 10.1016/j.ncl.2015.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.001</ArticleId><ArticleId IdType="pmc">PMC4670044</ArticleId><ArticleId IdType="pubmed">26515623</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R, Flynn LL, Pitout IL, Fletcher S, Wilton SD, Akkari PA. ALS genetics, mechanisms, and therapeutics: where are we now? Front Neurosci. 2019;13:1310. doi: 10.3389/fnins.2019.01310.097cd21b39bf48b0950c0db564d5c9d4</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim G, Gautier O, Tassoni-Tsuchida E, Ma XR, Gitler AD. ALS genetics: gains, losses, and implications for future therapies. Neuron. 2020;108:822&#x2013;842. doi: 10.1016/j.neuron.2020.08.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.08.022</ArticleId><ArticleId IdType="pmc">PMC7736125</ArticleId><ArticleId IdType="pubmed">32931756</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C, Rogelj B, Hortob&#xe1;gyi T, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323:1208&#x2013;1211. doi: 10.1126/science.1165942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Oakes JA, Davies MC, Collins MO. TBK1: a new player in ALS linking autophagy and neuroinflammation. Mol Brain. 2017;10:5. doi: 10.1186/s13041-017-0287-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-017-0287-x</ArticleId><ArticleId IdType="pmc">PMC5288885</ArticleId><ArticleId IdType="pubmed">28148298</ArticleId></ArticleIdList></Reference><Reference><Citation>eedharan J, Sr, Blair IP, Tripathi VB, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668&#x2013;1672. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Schissel SL, Schuchman EH, Williams KJ, Tabas I. Zn2+-stimulated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene. J Biol Chem. 1996;271:18431&#x2013;18436. doi: 10.1074/jbc.271.31.18431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.271.31.18431</ArticleId><ArticleId IdType="pubmed">8702487</ArticleId></ArticleIdList></Reference><Reference><Citation>Kornhuber J, Rhein C, Muller CP, Muhle C. Secretory sphingomyelinase in health and disease. Biol Chem. 2015;396:707&#x2013;736. doi: 10.1515/hsz-2015-0109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/hsz-2015-0109</ArticleId><ArticleId IdType="pubmed">25803076</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JK, Jin HK, Park MH, et al. Acid sphingomyelinase modulates the autophagic process by controlling lysosomal biogenesis in Alzheimer's disease. J Exp Med. 2014;211:1551&#x2013;1570. doi: 10.1084/jem.20132451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20132451</ArticleId><ArticleId IdType="pmc">PMC4113944</ArticleId><ArticleId IdType="pubmed">25049335</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong WY, Herr DR, Farooqui T, Ling EA, Farooqui AA. Role of sphingomyelinases in neurological disorders. Expert Opin Ther Targets. 2015;19:1725&#x2013;1742. doi: 10.1517/14728222.2015.1071794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/14728222.2015.1071794</ArticleId><ArticleId IdType="pubmed">26243307</ArticleId></ArticleIdList></Reference><Reference><Citation>Park MH, Jin HK, Bae JS. Potential therapeutic target for aging and age-related neurodegenerative diseases: the role of acid sphingomyelinase. Exp Mol Med. 2020;52:380&#x2013;389. doi: 10.1038/s12276-020-0399-8.c83739d0e4604ace88f605bf29c188de</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-020-0399-8</ArticleId><ArticleId IdType="pmc">PMC7156489</ArticleId><ArticleId IdType="pubmed">32203096</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkins RW, Canals D, Hannun YA. Roles and regulation of secretory and lysosomal acid sphingomyelinase. Cell Signal. 2009;21:836&#x2013;846. doi: 10.1016/j.cellsig.2009.01.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2009.01.026</ArticleId><ArticleId IdType="pmc">PMC3488588</ArticleId><ArticleId IdType="pubmed">19385042</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Xiang, Gulbins Erich, Zhang Yang. Oxidative stress triggers Ca-dependent lysosome trafficking and activation of acid sphingomyelinase. Cell Physiol Biochem. 2012;30:815&#x2013;826. doi: 10.1159/000341460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000341460</ArticleId><ArticleId IdType="pmc">PMC3777434</ArticleId><ArticleId IdType="pubmed">22890197</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith EL, Schuchman EH. The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases. FASEB J. 2008;22:3419&#x2013;3431. doi: 10.1096/fj.08-108043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.08-108043</ArticleId><ArticleId IdType="pmc">PMC2537423</ArticleId><ArticleId IdType="pubmed">18567738</ArticleId></ArticleIdList></Reference><Reference><Citation>Park MH, Lee JY, Park KH, et al. Vascular and neurogenic rejuvenation in aging mice by modulation of ASM. Neuron. 2018;100:167&#x2013;182. doi: 10.1016/j.neuron.2018.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.09.010</ArticleId><ArticleId IdType="pubmed">30269989</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu H, Lee S, Shang Y, et al. ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects. J Clin Invest. 2014;124:981&#x2013;999. doi: 10.1172/JCI72723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI72723</ArticleId><ArticleId IdType="pmc">PMC3938263</ArticleId><ArticleId IdType="pubmed">24509083</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell JC, McGoldrick P, Vance C, et al. Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion. Acta Neuropathol. 2013;125:273&#x2013;288. doi: 10.1007/s00401-012-1043-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1043-z</ArticleId><ArticleId IdType="pmc">PMC3549237</ArticleId><ArticleId IdType="pubmed">22961620</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A, Lyashchenko AK, Lu L, et al. ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function. Nat Commun. 2016;7:10465. doi: 10.1038/ncomms10465.320664c72a834d799df983f0633c7d56</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms10465</ArticleId><ArticleId IdType="pmc">PMC4742863</ArticleId><ArticleId IdType="pubmed">26842965</ArticleId></ArticleIdList></Reference><Reference><Citation>Hewitt C, Kirby J, Highley JR, et al. Novel FUS/TLS mutations and pathology in familial and sporadic amyotrophic lateral sclerosis. Arch Neurol. 2010;67:455&#x2013;461. doi: 10.1001/archneurol.2010.52.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2010.52</ArticleId><ArticleId IdType="pubmed">20385912</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler RG, Pedersen WA, Camandola S, Rothstein JD, Mattson MP. Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis. Ann Neurol. 2002;52:448&#x2013;457. doi: 10.1002/ana.10312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.10312</ArticleId><ArticleId IdType="pubmed">12325074</ArticleId></ArticleIdList></Reference><Reference><Citation>Arenas A, Kuang L, Zhang J, Kingren MS, Zhu H. FUS regulates autophagy by mediating the transcription of genes critical to the autophagosome formation. J Neurochem. 2021;157:752&#x2013;763. doi: 10.1111/jnc.15281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15281</ArticleId><ArticleId IdType="pmc">PMC8364620</ArticleId><ArticleId IdType="pubmed">33354770</ArticleId></ArticleIdList></Reference><Reference><Citation>Baskoylu SN, Chapkis N, Unsal B, et al. Disrupted autophagy and neuronal dysfunction in C. elegans knockin models of FUS amyotrophic lateral sclerosis. Cell Rep. 2022;38:110195. doi: 10.1016/j.celrep.2021.110195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.110195</ArticleId><ArticleId IdType="pubmed">35081350</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrov D, Moussy A, Hermine O Mans&#xfb01;eld C, author. ALS clinical trials review: 20 years of failure. Are we any closer to registering a new treatment? Front Aging Neurosci. 2017;9:68. doi: 10.3389/fnagi.2017.00068.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00068</ArticleId><ArticleId IdType="pmc">PMC5360725</ArticleId><ArticleId IdType="pubmed">28382000</ArticleId></ArticleIdList></Reference><Reference><Citation>Kornhuber J, Tripal P, Reichel M, et al. Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications. Cell Physiol Biochem. 2010;26:9&#x2013;20. doi: 10.1159/000315101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000315101</ArticleId><ArticleId IdType="pubmed">20502000</ArticleId></ArticleIdList></Reference><Reference><Citation>Park MH, Park KH, Choi BJ, et al. Discovery of a dual-action small molecule that improves neuropathological features of Alzheimer's disease mice. Proc Natl Acad Sci U S A. 2022;119:e2115082119. doi: 10.1073/pnas.2115082119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2115082119</ArticleId><ArticleId IdType="pmc">PMC8784098</ArticleId><ArticleId IdType="pubmed">35027452</ArticleId></ArticleIdList></Reference><Reference><Citation>Horinouchi K, Erlich S, Perl DP, et al. Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease. Nat Genet. 1995;10:288&#x2013;293. doi: 10.1038/ng0795-288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0795-288</ArticleId><ArticleId IdType="pubmed">7670466</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiihashi G, Ito D, Yagi T, Nihei Y, Ebine T, Suzuki N. Mislocated FUS is sufficient for gain-of-toxic-function amyotrophic lateral sclerosis phenotypes in mice. Brain. 2016;139:2380&#x2013;2394. doi: 10.1093/brain/aww161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww161</ArticleId><ArticleId IdType="pubmed">27368346</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>